Epsolin 50mg Injection (2ml Each) contains Phenytoin sodium at a concentration of 50mg/ml, an antiepileptic agent primarily used in the management of tonic-clonic (grand mal) seizures and complex partial seizures. Phenytoin acts by stabilizing neuronal membranes and decreasing seizure activity by increasing efflux or decreasing influx of sodium ions across cell membranes in the motor cortex during generation of nerve impulses. Epsolin Injection is indicated for the control and prevention of seizures, particularly in patients who are unable to take oral medication or require rapid therapeutic levels. It is administered intravenously or intramuscularly under strict medical supervision, with dosage individualized based on patient response and serum phenytoin levels to avoid toxicity. Common adverse effects include dizziness, nystagmus, ataxia, and gastrointestinal disturbances, while serious reactions may involve cardiac arrhythmias or hypersensitivity. Caution is advised in patients with hepatic impairment, cardiovascular disease, or hypersensitivity to phenytoin. Continuous monitoring of serum levels and clinical status is essential to optimize therapy and minimize adverse effects. Epsolin Injection should be used as part of a comprehensive epilepsy management plan, under the guidance of a healthcare professional experienced in anticonvulsant therapy.